MedPath
TGA Approval

ZolaCos CP combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack (125685)

125685

ZolaCos CP combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

AstraZeneca Pty Ltd

December 1, 2006

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-06003-3

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06002-3

Active Ingredients

bicalutamide

goserelin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZolaCos CP combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack (125685) - TGA 批准文号 | MedPath